Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Norharmane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.74 |
| ▸ | CHUK | O15111 | 7/20 | 0.96 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.96 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.96 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.96 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.96 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.96 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.96 |
| ▸ | GABRP | O00591 | 1/20 | 0.96 |
| ▸ | GABRD | O14764 | 1/20 | 0.96 |
| ▸ | IKBKB | O14920 | 1/20 | 0.96 |
| ▸ | AURKA | O14965 | 1/20 | 0.96 |
| ▸ | PIM1 | P11309 | 1/20 | 0.96 |
| ▸ | TOP1 | P11387 | 1/20 | 0.96 |
| ▸ | IDO1 | P14902 | 1/20 | 0.96 |
| ▸ | HPGD | P15428 | 1/20 | 0.96 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.96 |
| ▸ | MAOA | P21397 | 1/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbazole SCHEMBL18684843 | 0.98 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL25834 | 0.98 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL29370219 | 0.98 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL9486853 | 0.98 | CHUK (1.00) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL8686167 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL8683826 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL29217000 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL28902872 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL21378153 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 | |
| Norharmane SCHEMBL29809643 | 0.96 | CHUK (0.96) | CHUKGABRA1GABRG2GABRB3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3227291-A1 | N-SUBSTITUTED BETA-CARBOLINIUM COMPOUNDS AS POTENT P-GLYCOPROTEIN INDUCERS | Council of Scientific and Industrial Research (IN) | 2017-10-11 | — | — | EP | disclosed |
| US-4148922-A | 3-[2-(Dialkylamino)ethyl]-2-(benzyl)indoles | WARNER-LAMBERT COMPANY (US) | 1979-04-10 | — | — | US | disclosed |